Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jing-Si-Herbal-Tea in COVID-19
NCT04967755Unknown
- Start
- Jun 2021
- Primary completion
- Aug 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, open-label trial of Jing Si Herbal Tea in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoints: Viral shedding at 3 months and Decline of acute inflammation at 3 months. Status: unknown.
02
Drugs
Jing Si Herbal Tea
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04967755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967755.